The clinical outcomes are complex and often involve multi-system congestion. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical outcomes, imaging inspections, laboratory tests and pathological activation.
The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of rheumatoid arthritis treatment programs require individual development, typically including drug therapy, rehabilitation interventions, regular follow-up management, etc. In recent years, with the development of therapeutic, immune-regulatory treatments and precision medicine, many autoimmune and rheumatic immune diseases that were previously difficult to treat have been significantly improved.
Therapeutic efficacy and adverse reactions need to be closely monitored and timely adjusted according to the course of treatment. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of rheumatoid arthritis. The platform serves a team of internationally authoritative experts in the field of self-immunity and rheumatic immunity in China, providing the following services to patients: 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.